Each vial of BPC-157 supplied by Pharma-One Peptides is produced under controlled conditions to ensure batch consistency, compound stability, and reliable research performance
Phe 28 of GLP-1 is critical for binding of GLP-1 to GLP-1R and interacts with Leu 32* , Thr 35 *, Val 36 * and Trp 39 *
Bypassing it does not make the product safer
What we are developing could be used as something like maintenance therapy where you could get subcutaneous injections every 3 to 6 months. The market opportunity also resulted in a dramatic legal battle between Pfizer and Novo Nordisk last year, when the two companies fought over buying Metsera, a start-up developing weight-loss drugs
The mechanism is real, the evidence is consistent, and the dosing window is narrow
It takes a little planning and discipline, but the quality and reliability of your research outcomes are more than worth the effort